Controlled studies of the efficacy and safety of combined probucol-colestipol therapy

This publication has 11 references indexed in Scilit:

• Low-dose colestipol plus probucol for hypercholesterolemia
  The American Journal of Cardiology, 1984
• Probucol with Colestipol in the Treatment of Hypercholesterolemia
  Annals of Internal Medicine, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Electrocardiographic effects of probucol. A controlled prospective clinical trial
  European Journal of Clinical Pharmacology, 1984
• Reduction of Serum Cholesterol in Heterozygous Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1983
• Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat
  Atherosclerosis, 1981
• Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
  New England Journal of Medicine, 1981
• Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia
  Metabolism, 1980
• Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
  New England Journal of Medicine, 1980
• A two-year crossover therapeutic trial with halofenate and clofibrate
  The Lancet Healthy Longevity, 1976